Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CIR "Proactive" Approach To Seeking Controversial Ingredients Data Urged

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review Expert Panel should be "proactive" in conducting literature searches on controversial cosmetic ingredients up for re-review, CIR Director and Scientific Coordinator Alan Anderson urged during the panel's Sept. 10-11 meeting in Washington, D.C.
Advertisement

Related Content

Parabens Tentative Amended Final Report Issued By CIR
Parabens Tentative Amended Final Report Issued By CIR
Butylparaben Toxicity Testing Recommended By NTP Board
Butylparaben Toxicity Testing Recommended By NTP Board
Butoxyethanol “Safe As Used” Despite NTP Carcinogenicity Issues – CIR
Butoxyethanol “Safe As Used” Despite NTP Carcinogenicity Issues – CIR
Methacrylate Ingredients Designated Safe For Professional Use By CIR
Methacrylate Ingredients Designated Safe For Professional Use By CIR
Phthalates "Safe As Used" Recommendation To Be Reevaluated By CIR
Phthalates "Safe As Used" Recommendation To Be Reevaluated By CIR
Advertisement
UsernamePublicRestriction

Register

RS009620

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel